56539-06-1

Usage

InChI:InChI=1/C12H11ClN2O2S/c13-9-5-7-10(8-6-9)18(16,17)15-12-4-2-1-3-11(12)14/h1-8,15H,14H2

Upstream product

• 4547-68-6 p-chlorobenzenesulfonyl azide 
• 62-53-3 aniline 
• 98-60-2 4-chlorobenzenesulfonyl chloride 
• 95-54-5 1,2-diamino-benzene 
• 88-74-4 2-nitro-aniline 
• 2751-25-9 p-chlorophenylsulfonyl hydrazide 

Relevant academic research and scientific papers

Palladium(II) complexes assembled on solid materials: as catalysts for the –NO2 (nitro) to –NH2 (amine) reactions

Abstract: Herein, a new series of [PdCl2(L)2] complexes where ligands are monodentate amine ligands bearing sulfonamide groups were synthesized, characterized using various techniques such as NMR, FT-IR, UV–Vis, and sc-XRD and invest

BISSULFONAMIDE COMPOUNDS AS AGONISTS OF GALR1, COMPOSITIONS, AND METHODS OF USE

Embodiments of the present invention provide bissulfonamide compounds that are agonists of GalR1. The present invention further provides compositions comprising bissulfonamide compounds that are agonists of GalR1, and methods of use of such compounds and compositions.

Sulfonamide derivatives and drugs containing the same as the active ingredient

The present invention discloses a sulfonamide derivative represented by the following formula (1): [wherein A represents a nitrogen atom, —CH═, etc.; Z represents an oxygen atom, etc.; Ar1represents an aryl group, etc.; Ar2represents an alkyl group, etc.; Rarepresents a hydrogen atom, etc.; Rbrepresents a hydrogen atom, etc.; and Rcrepresents an alkyl group, etc.], or a salt thereof; and drugs containing the derivative or a salt thereof as an active ingredient. This compound exhibits radical scavenging action, gastric mucous secretion augmenting action, and anti-HP action, and thus is effective as a peptic ulcer therapeutic agent.